IDA Ireland has welcomed today’s joint-announcement by Bristol-Myers Squibb and South Korean company SK Biotek Co., Ltd of agreement for SK Biotek to acquire Bristol-Myers Squibb’s Active Pharmaceutical Ingredients (API) Manufacturing Facility in Swords, Co Dublin.

•    SK Biotek is the first Korean company to invest in pharmaceutical manufacturing in Ireland and anticipates further investment by adding R&D, marketing and additional manufacturing capabilities
•    Bristol-Myers Squibb shifts manufacturing focus in Ireland to reflect growing biologics portfolio with ongoing investment in Cruiserath biologics facility

Read the full article here